Abstract
Background
Hair loss causes significant psychosocial distress to patients. Health utility measurements offer an objective, quantitative assessment of health-related quality of life (QOL).
Methods
We performed a prospective cohort study on patients with hair loss between January 1, 2018 and December 31, 2020. Patient metrics were compared with layperson perception of alopecia, prospectively collected between August 1 and December 31, 2017. Health utility measures were quantified using the visual analog scale (VAS), standard gamble (SG), and time trade-off (TTO) in quality-adjusted life-years (QALYs) and relative to the minimal clinically important difference (MCID). Bonferroni correction to the significance threshold was performed.
Results
Thirty-one patients with alopecia were compared with 237 laypeople. Patient metrics for female hair loss were all significantly lower than laypeople measures (VAS QALYs 0.65 ± 0.21 vs. 0.83 ± 0.18, p = 0.0001). Mean SG QALYs were lower for patients in the male alopecia state (0.86 ± 0.23 vs. 0.96 ± 0.12, p = 0.0278). Post-hair transplant improvement in TTO was significantly greater for patients (+ 0.08 ± 0.12 vs. + 0.02 ± 0.09, p = 0.0070) and significantly more often exceeded the MCID (45.2% vs. 16.9%, p = 0.0006).
Conclusions
Alopecia negatively impacts QOL, and the true patient experience is more taxing than what is perceived by laypeople. Hair transplantation improves QOL more for male patients than common perception.
Level of Evidence IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
Data Availability
Dr. Xiao and Ms. Yau had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
References
Price VH (1999) Treatment of hair loss. N Engl J Med 341(13):964–973. https://doi.org/10.1056/NEJM199909233411307
Stough D, Stenn K, Haber R et al (2005) Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc 80(10):1316–1322. https://doi.org/10.4065/80.10.1316
Han S-H, Byun J-W, Lee W-S et al (2012) Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann Dermatol 24(3):311–318. https://doi.org/10.5021/ad.2012.24.3.311
Bater KL, Ishii M, Joseph A, Su P, Nellis J, Ishii LE (2016) Perception of hair transplant for androgenetic alopecia. JAMA Facial Plast Surg. 18(6):413–418. https://doi.org/10.1001/jamafacial.2016.0546
van der Donk J, Passchier J, Dutree-Meulenberg RO, Stolz E, Verhage F (1991) Psychologic characteristics of men with alopecia androgenetica and their modification. Int J Dermatol 30(1):22–28. https://doi.org/10.1111/j.1365-4362.1991.tb05874.x
Girman CJ, Rhodes T, Lilly FR et al (1998) Effects of self-perceived hair loss in a community sample of men. Dermatology 197(3):223–229. https://doi.org/10.1159/000018001
Prinsen CAC, Lindeboom R, Sprangers MAG, Legierse CM, de Korte J (2010) Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol 130(5):1318–1322. https://doi.org/10.1038/jid.2009.404
Sadick NS (2018) New-generation therapies for the treatment of hair loss in men. Dermatol Clin 36(1):63–67. https://doi.org/10.1016/j.det.2017.08.003
Guo H, Gao WV, Endo H, McElwee KJ (2017) Experimental and early investigational drugs for androgenetic alopecia. Expert Opin Investig Drugs 26(8):917–932. https://doi.org/10.1080/13543784.2017.1353598
Rousso DE, Kim SW (2014) A review of medical and surgical treatment options for androgenetic alopecia. JAMA Facial Plast Surg 16(6):444–450. https://doi.org/10.1001/jamafacial.2014.316
Chen JX, Justicz N, Lee LN (2018) Platelet-rich plasma for the treatment of androgenic alopecia: a systematic review. Facial Plast Surg 34(6):631–640. https://doi.org/10.1055/s-0038-1660845
Justicz N, Derakhshan A, Chen JX, Lee LN (2020) Platelet-rich plasma for hair restoration. Facial Plast Surg Clin North Am 28(2):181–187. https://doi.org/10.1016/j.fsc.2020.01.009
Chang EM, Saigal CS, Raldow AC (2020) Explaining health state utility assessment. JAMA 323(11):1085–1086. https://doi.org/10.1001/jama.2020.0656
Garza AG, Wyrwich KW (2003) Health utility measures and the standard gamble. Acad Emerg Med 10(4):360–363. https://doi.org/10.1197/aemj.10.4.360
Ara R, Brazier J, Zouraq IA (2017) The use of health state utility values in decision models. Pharmacoeconomics 35(Suppl 1):77–88. https://doi.org/10.1007/s40273-017-0550-0
Gupta M, Mysore V (2016) Classifications of patterned hair loss: a review. J Cutan Aesthet Surg 9(1):3. https://doi.org/10.4103/0974-2077.178536
Christopher AN, Morris MP, Patel V, Klifto K, Fischer JP (2021) A systematic review of health state utility values in the plastic surgery literature. Plast Reconstr Surg Glob Open 9(11):e3944. https://doi.org/10.1097/GOX.0000000000003944
Abt NB, Quatela O, Heiser A, Jowett N, Tessler O, Lee LN (2018) Association of hair loss with health utility measurements before and after hair transplant surgery in men and women. JAMA Facial Plast Surg 20(6):495–500. https://doi.org/10.1001/jamafacial.2018.1052
Heiser A, Jowett N, Occhiogrosso J, Tessler O, Tan OT (2020) Societal-perceived health utility of hypertrophic facial port-wine stain and laser treatment. Facial Plast Surg Aesthet Med. https://doi.org/10.1089/fpsam.2020.0059
Faris C, Tessler O, Heiser A, Hadlock T, Jowett N (2018) Evaluation of societal health utility of facial palsy and facial reanimation. JAMA Facial Plast Surg 20(6):480–487. https://doi.org/10.1001/jamafacial.2018.0866
Faris C, Heiser A, Quatela O et al (2020) Health utility of rhinectomy, surgical nasal reconstruction, and prosthetic rehabilitation. Laryngoscope 130(7):1674–1679. https://doi.org/10.1002/lary.28480
Lenert LA, Cher DJ, Goldstein MK, Bergen MR, Garber A (1998) The effect of search procedures on utility elicitations. Med Decis Mak 18(1):76–83. https://doi.org/10.1177/0272989X9801800115
Feeny D, Krahn M, Prosser LA, Salomon JA. 7.7.1 How to interpret utility scores. In: Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG, eds. Cost-effectiveness in health and medicine. 2nd ed. Oxford University Press; 2016:179
Pickard AS, Neary MP, Cella D (2007) Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 5:70. https://doi.org/10.1186/1477-7525-5-70
Schünemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Guyatt GH (2003) Evaluation of the minimal important difference for the feeling thermometer and the St. George’s Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol 56(12):1170–1176. https://doi.org/10.1016/s0895-4356(03)00115-x
Feeny D (2005) The roles for preference-based measures in support of cancer research and policy. In: Lipscomb J, Gotay CC, Snyder C (eds) Outcomes assessment in cancer: measures, methods, and applications. Cambridge University Press, pp 69–92
Feeny D (2005) Preference-based measures: utility and quality-adjusted life years. In: Fayers P, Hays R (eds) Assessing quality of life in clinical trials, 2nd edn. Oxford University Press, pp 405–429
Byun S, Hong P, Bezuhly M (2016) Public perception of the burden of microtia. J Craniofac Surg 27(7):1665–1669. https://doi.org/10.1097/SCS.0000000000002900
Sinno HH, Ibrahim AMS, Izadpanah A et al (2012) Utility outcome assessment of the aging neck following massive weight loss. Otolaryngol Head Neck Surg 147(1):26–32. https://doi.org/10.1177/0194599812439028
Dey JK, Ishii LE, Nellis JC, Boahene KDO, Byrne PJ, Ishii M (2017) Comparing patient, casual observer, and expert perception of permanent unilateral facial paralysis. JAMA Facial Plast Surg 19(6):476–483. https://doi.org/10.1001/jamafacial.2016.1630
Acknowledgements
The authors would like to acknowledge Jessica Occhiogrosso, BS and Alyssa Heiser, BA for their contributions in data collection.
Funding
This project was not supported by any external grants or funds. The authors assume full responsibility for the accuracy and completeness of the ideas presented.
Author information
Authors and Affiliations
Contributions
Dr. Xiao, Dr. Burks, and Ms. Yau were responsible for the conception and design of this work, as well as drafting the manuscript. Ms. Yau was responsible for data acquisition. Dr. Xiao was responsible for statistical analysis. All authors participated in the analysis and interpretation of the data and critically revised the manuscript for important intellectual content.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical Approval
The authors obtained approval from the MGB IRB prior to performing the reported research (protocol #2019P003415).
Informed Consent
All included laypersons and patients completing surveys for analyzed data provided informed consent prior to doing so.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xiao, R., Burks, C.A., Yau, J. et al. Health Utility Measures Among Patients with Androgenetic Alopecia After Hair Transplant. Aesth Plast Surg 47, 631–639 (2023). https://doi.org/10.1007/s00266-022-03066-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-022-03066-4